Zomedica Corp. ZOM
$ 0.12
-0.17%
Quarterly report 2024-Q2
added 08-14-2024
Zomedica Corp. Financial Ratios 2011-2024 | ZOM
Annual Financial Ratios Zomedica Corp.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.0 | -14.4 | -16.2 | 19.8 | -1.3 | -4.8 | -21.7 | -3.6 | -5.0 | -0.9 | - | - | - |
P/S |
5.4 | 12.9 | 72.0 | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.0 | -0.0 | - | -0.1 | -0.2 | -0.2 | -0.1 | -0.1 | - | - | - | - | - |
EV (Enterprise Value) |
137 M | 230 M | 112 M | 273 M | 27.5 M | 81.1 M | 172 M | -3.02 M | 204 K | 73.2 K | 977 | - | - |
EBITDA per Share |
-0.03 | -0.02 | -0.02 | 0.0468 | -0.179 | -0.175 | -0.0912 | -0.0545 | -0.0424 | -0.228 | - | - | - |
EV/EBITDA |
8.8 | 19.7 | -1.3 | -4.8 | -21.5 | -2.1 | -1.6 | 1.8 | - | - | - | ||
PEG |
0.09 | 0.41 | 0.75 | 0.16 | 0.24 | 0.05 | 1.73 | 0.22 | 0.3 | 0.02 | - | - | - |
P/B |
0.6 | 0.9 | 1.1 | 6.6 | 12.4 | 22.1 | 39.8 | 2.6 | 1.5 | 0.3 | - | - | - |
P/CF |
-8.6 | -21.0 | -20.8 | 16435.7 | -1.6 | -6.8 | -24.1 | -3.9 | -5.1 | -1.0 | - | - | - |
ROE % |
-14.39 | -6.36 | -6.79 | 33.12 | -944.14 | -455.23 | -183.84 | -71.93 | -30.05 | -38.10 | - | - | - |
ROA % |
-13.64 | -6.09 | -6.56 | 26864.87 | -472.97 | -275.92 | -154.63 | -66.36 | -29.24 | -38.10 | - | - | - |
ROCE % |
-13.16 | -8.20 | -7.89 | 27282.36 | -944.15 | -453.36 | -184.27 | -71.93 | -30.05 | -40.00 | - | - | - |
Current Ratio |
19.2 | 22.9 | 29.5 | 41.3 | 0.9 | 1.6 | 5.1 | 12.9 | 37.0 | 21.0 | - | - | - |
DSO |
13.0 | 8.8 | 20.4 | - | - | - | - | - | - | - | - | - | - |
DIO |
182.5 | 186.9 | 481.7 | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | 211.2 | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
195.5 | 195.7 | 502.1 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
195.5 | 195.7 | 290.9 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Zomedica Corp.
2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.024 | - | -0.001 | -0.005 | -0.007 | - | -0.005 | -0.005 | -0.004 | - | -0.006 | -0.005 | -0.04 | - | -0.01 | -0.02 | -0.02 | - | -0.03 | -0.02 | -0.12 | - | -0.02 | -0.04 | -0.02 | - | -0.02 | -0.02 | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.03 | - | - | -0.01 | -0.01 | - | -0.01 | -0.01 | - | - | -0.01 | -0.01 | - | - | -0.01 | -0.02 | -0.02 | - | -0.02 | -0.02 | -0.11 | - | -0.02 | -0.04 | -0.02 | - | -0.02 | -0.02 | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-13.87 | -4.64 | -6.50 | -8.17 | -8.12 | -5.30 | -7.64 | -8.12 | -7.84 | -5.50 | -15.25 | -22.67 | -31.35 | -24.95 | -160.75 | -286.80 | -391.15 | -807.80 | -860.03 | -776.47 | -775.05 | -224.94 | -272.37 | -267.56 | -190.44 | -125.41 | -125.41 | -77.98 | -41.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-13.15 | -4.37 | -6.14 | -7.73 | -7.74 | -5.10 | -7.39 | -7.90 | -7.67 | -5.41 | -12.94 | -18.18 | -24.52 | -19.26 | -87.29 | -147.79 | -197.25 | -404.66 | -436.32 | -399.96 | -411.16 | -136.34 | -176.23 | -184.46 | -146.22 | -105.48 | -105.48 | -65.59 | -35.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | -2.45 | -4.91 | -7.11 | -6.26 | -8.62 | -8.51 | -8.23 | -5.67 | -15.46 | -22.90 | -31.14 | -24.43 | -160.17 | -286.12 | -390.06 | -807.80 | -858.25 | -772.96 | -772.28 | -223.20 | -270.75 | -267.85 | -190.70 | -125.89 | -125.89 | -78.34 | -42.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
19.7 | 19.2 | 19.4 | 18.0 | 16.9 | 22.9 | 20.9 | 29.8 | 31.1 | 29.5 | 46.7 | 65.4 | 95.4 | 21.2 | 21.2 | 21.2 | 21.2 | 2.0 | 2.0 | 2.0 | 2.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
19.2 | - | 14.4 | 8.2 | 8.5 | - | 6.9 | - | 3.8 | - | 22.2 | 36.5 | 7.1 | - | 277.7 | 26315.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
274.2 | - | 169.4 | 147.5 | 152.1 | - | 260.4 | 310.0 | 291.3 | - | 5621.6 | 1398.6 | 2354.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
113.2 | - | - | - | - | - | - | - | - | - | 19162.7 | 5352.6 | 18074.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
293.4 | - | 183.8 | 155.7 | 160.6 | - | 267.2 | 310.0 | 295.1 | - | 5643.8 | 1435.1 | 2361.8 | - | 277.7 | 26315.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
180.1 | - | 183.8 | 155.7 | 160.6 | - | 267.2 | 310.0 | 295.1 | - | -13518.9 | -3917.5 | -15712.3 | - | 277.7 | 26315.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency